Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2019-2025

SKU ID : QYR-14199170

Publishing Date : 14-May-2019

No. of pages : 93

PRICE
3900
7800


  • Acute coronary syndrome (ACS) is a syndrome (set of signs and symptoms) due to decreased blood flow in the coronary arteries such that part of the heart muscle is unable to function properly or dies. The most common symptom is chest pain, often radiating to the left shoulder or angle of the jaw, crushing, central and associated with nausea and sweating. Many people with acute coronary syndromes present with symptoms other than chest pain, particularly, women, older patients, and patients with diabetes mellitus.
    Increase in geriatric population and rise in the incidence of cardiac disorders are the major factors that drive the market growth. However, stringent government regulations for the approval of drugs are expected to restrain the market growth. Improvement in healthcare facilities in emerging regions such as Asia-Pacific and LAMEA are expected to provide new growth opportunities for the market during the analysis period.
    In 2018, the global Acute Coronary Syndrome (ACS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Acute Coronary Syndrome (ACS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Coronary Syndrome (ACS) development in United States, Europe and China.

    The key players covered in this study
    Dexa Medica
    GlaxoSmithKline
    Novartis
    Pfizer
    Sanofi
    Serum Institute of India
    Biogen Inc
    Eli Lilly and Company

    Market segment by Type, the product can be split into
    Monotherapy
    Combination Therapy

    Market segment by Application, split into
    Hospitals
    Ambulatory Surgical Center
    Diagnostic Centers

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Acute Coronary Syndrome (ACS) status, future forecast, growth opportunity, key market and key players.
    To present the Acute Coronary Syndrome (ACS) development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Acute Coronary Syndrome (ACS) are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.